Epic Sciences

07.06.2016 / Wall Street Journal Back to News Listings

Test aids prostate cancer treatment.

Genomic Health Inc. has struck a deal to commercialize a new blood test that can help advanced prostate cancer patients decide whether to try costly new-generation drugs or rely on much cheaper traditional chemotherapy to improve their chances for survival.

Read the Wall Street Journal article.

Learn more about the test at www.arv7.com.

Learn more about the epic sciences platform and technology.